Pap Self-Collection Devices Will Be Considered At US FDA Workshop
US FDA will hold a workshop to discuss whether allowing women to self-collect cervical cells for use in Pap tests would help the test reach rural and other underserved groups.
You may also be interested in...
A group of manufacturers and clinicians is asking the US agency to allow more discussion between manufacturers, labs and clinicians of how genetic factors could influence drug effectiveness – an area known as pharmacogenomics (PGx). The FDA had previously taken several steps to limit these communications.
The US FDA says Bayer has successfully recovered unsold Essure units and completed enrollment in a Sec. 522 postmarket study, fulfilling deadlines set at a year from the date the devices were taken off the US market.
Manufacturers won’t need to submit 510(k)s for powered wheeled stretchers under a new order from the US FDA.